drugset / Trial / NCT02505191
Pilot Pharmacokinetic Study of a Prolonged-release Formulation of St. John's Wort Extract Ze 117
RandomizedParallel-groupOpen-labelTreatment
Summary
A pilot phase I, randomised, open mono-center, two parallel group clinical trial investigating the pharmacokinetics of a prolonged-release formulation in comparison to an immediate-release formulation of St. John's wort extract Ze 117 in healthy male volunteers under fasting condition.
Timeline
- Start
- 2015-11
- Primary completion
- 2015-11
- Completion
- 2015-11
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | St. John's wort extract Ze 117 | Unknown | 250 mg | — |
| Subject | St. John's wort extract Ze 117 | Unknown | 500 mg | — |
Indications
No indication recorded.